Related Experiment Video
Updated: Jun 2, 2025

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
Myocardial infarction in multivessel disease: Does presence of chronic total occlusion make a difference?
Dávid Bauer1, Šimon Benjamin Špányi2, Marek Neuberg3
1Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic; Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Insights
Myocardial infarction with multivessel disease and chronic total occlusion (CTO) did not show increased 1-year mortality compared to matched patients without CTO. Coronary artery bypass grafting (CABG) offered excellent survival regardless of CTO presence.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Myocardial infarction (MI) in patients with multivessel disease (MVD) and chronic total occlusion (CTO) is linked to high mortality.
- The impact of CTO on all-cause mortality in a matched cohort of MVD patients without CTO remains unclear.
Purpose of the Study:
- To analyze clinical characteristics, presenting symptoms, and survival of patients with MI and MVD.
- To evaluate the impact of CTO on 1-year mortality in this patient population.
Main Methods:
- A propensity score matching (PSM) analysis was conducted on 1309 MI patients with MVD.
- Patients were compared between a CTO group (n=90) and a control group without CTO (n=90) based on age, gender, and MI type.
Main Results:
- No significant differences were observed in presenting symptoms or initial heart rhythm between the CTO and control groups.
- 1-year all-cause mortality was 23.3% in the CTO group and 18.9% in the control group (p=0.44).
- Percutaneous coronary intervention (PCI) was performed in 64.4% of both groups; Coronary Artery Bypass Grafting (CABG) was performed in 18.8% and 24.4% respectively.
Conclusions:
- No significant difference in 1-year mortality was found between MI patients with MVD and CTO compared to a matched cohort without CTO.
- Patients treated with CABG demonstrated excellent 1-year survival, irrespective of CTO presence.
Background And Aims:
Myocardial infarction (MI) in multivessel disease (MVD) and chronic total occlusion (CTO) is associated with high mortality. However, all-cause mortality of matched cohort without a CTO is unclear. Our aim was to analyse clinical characteristics, presenting symptoms, and survival of patients with MI in MVD and the possible impact of CTO on 1-year mortality.
Methods:
All MI patients with MVD (two or three vessel disease) hospitalized in our center from January 2020 to September 2022 (1309 patients) were selected. We conducted a propensity score matching (PSM) analysis based on age, gender, type of MI, and compared patients with CTO (CTO group, n = 90) and without CTO (Control group, n = 90).
Results:
We observed no difference in presenting clinical symptoms and initial heart rhythm between the groups. 1-year follow-up shows all-cause mortality rate of 23.3 % (n = 21) in the CTO group (Mean survival [MS] = 292.1 days, 95 % CI = 263.8 to 320.4) and 18.9 % (n = 17) in the Control group (MS = 310.2 days, 95 % CI = 285.3 to 335.2), p = 0.44. PCI alone was performed in 64.4 % (n = 58) in both groups, CABG in 18.8 % (n = 17) and 24.4 % (n = 22) (CTO vs. Control group respectively). Combination of PCI and CABG occurred in 8.8 % (n = 8) in both groups. Conservative treatment was chosen for 7 CTO and 2 Control group patients.
Conclusion:
We observed no 1-year mortality difference in patients with MI, MVD and a CTO compared to a matched cohort of patients with MI, MVD without CTO. Excellent 1-year survival was observed in patients treated by CABG, irrespective of CTO presence.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016